300% Aktienanstieg:
Warum diese Kupferstory noch besser wird!
Anzeige

CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion

21,15 EUR
+0,33 %+0,07
5. Nov, 09:09:52 Uhr, Lang & Schwarz
Kommentare 95
Summer.76
Summer.76, 21.01.2021 6:56 Uhr
0
CareDx Announces Pricing of Public Offering of Common Stock https://finance.yahoo.com/news/caredx-announces-pricing-public-offering-035600029.html today announced the pricing of an underwritten public offering of 1,923,077 shares of its common stock at a public offering price of $91.00 per share. The gross proceeds to CareDx from this offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $175,000,007. In addition, CareDx has granted the underwriters a 30 day option to purchase up to 288,461 additional shares of its common stock offered in the public offering on the same terms and conditions. The offering is expected to close on or about January 25, 2021, subject to the satisfaction of customary closing conditions. ...
Summer.76
Summer.76, 19.01.2021 22:44 Uhr
0
CareDx Announces Proposed Public Offering of Common Stock https://finance.yahoo.com/news/caredx-announces-proposed-public-offering-211400257.html ...today announced that it intends to offer and sell, subject to market and other conditions, up to $175.0 million of shares of its common stock in an underwritten public offering. CareDx also expects to grant the underwriters of the offering a 30 day option to purchase up to an additional $26.25 million of shares of its of common stock offered in the public offering on the same terms and conditions. All of the shares will be offered and sold by CareDx. ...
Summer.76
Summer.76, 19.01.2021 12:40 Uhr
0
👍
T
Tommy87, 19.01.2021 11:49 Uhr
0
Im organ Bereich gibt es noch transmedics. Auch ein absoluter game changer. Das wird die Organspenden Revolutionieren!
Summer.76
Summer.76, 11.01.2021 15:30 Uhr
0
CareDx Reports Preliminary Fourth Quarter and Full Year 2020 Results https://www.globenewswire.com/news-release/2021/01/11/2156127/0/en/CareDx-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2020-Results.html
Summer.76
Summer.76, 08.01.2021 15:34 Uhr
0
CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers http://www.globenewswire.com/news-release/2021/01/08/2155496/0/en/CareDx-Agrees-to-Acquire-TransChart-and-Expands-EMR-Connectivity-to-Over-90-Centers.html Acquisition will build on CareDx’s digital capabilities and continue deepening the moat with transplant centers ...
Summer.76
Summer.76, 07.01.2021 15:08 Uhr
0
CareDx Announces AlloID and Exclusive Partnership with IDbyDNA https://www.globenewswire.com/news-release/2021/01/07/2154794/0/en/CareDx-Announces-AlloID-and-Exclusive-Partnership-with-IDbyDNA.html AlloID is a Transplant Patient-Specific Metagenomic Infectious Disease Test Platform, Furthering CareDx’s Innovation in Multi-Modality Surveillance Care ...
Summer.76
Summer.76, 04.01.2021 15:25 Uhr
0
CareDx’s AlloSeq HCT Wins Tender for French Stem Cell Transplant Patient Surveillance https://www.globenewswire.com/news-release/2021/01/04/2152520/0/en/CareDx-s-AlloSeq-HCT-Wins-Tender-for-French-Stem-Cell-Transplant-Patient-Surveillance.html CareDx wins a 2-year competitive tender with the French National Blood Service, Établissement Français du Sang ...
Summer.76
Summer.76, 03.01.2021 14:48 Uhr
0
CareDx: Stock To Achieve Significant Long-Term Growth https://seekingalpha.com/article/4397022-caredx-stock-to-achieve-significant-long-term-growth Summary CareDx offers organ testing products that are non-invasive alternatives to more invasive traditional tests. The organ transplant market is expected to grow through 2027, creating a tailwind for CareDx. While the company's growth is strong and above-average, the valuation and near overbought level needs to be considered. ...
Summer.76
Summer.76, 22.12.2020 16:31 Uhr
0
CareDx Celebrates the Long-Awaited Passage of the Immuno Bill http://www.globenewswire.com/news-release/2020/12/22/2149535/0/en/CareDx-Celebrates-the-Long-Awaited-Passage-of-the-Immuno-Bill.html Partners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients ...
Summer.76
Summer.76, 10.12.2020 16:00 Uhr
0
CareDx price target raised to $75 from $62 at Raymond James https://thefly.com/landingPageNews.php?id=3210563&headline=CDNA-CareDx-price-target-raised-to--from--at-Raymond-James
Summer.76
Summer.76, 01.12.2020 16:26 Uhr
0
CareDx Announces First AlloSure Pediatrics Publication https://www.einnews.com/pr_news/531827412/caredx-announces-first-allosure-pediatrics-publication
Summer.76
Summer.76, 17.11.2020 15:34 Uhr
0
CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart https://finance.yahoo.com/news/caredx-receives-medicare-reimbursement-pricing-100000177.html
Summer.76
Summer.76, 08.11.2020 10:31 Uhr
0
New Publication Shows CareDx’s AlloSure May Be Effective for Monitoring BK Virus in Transplant Patients https://www.globenewswire.com/news-release/2020/11/06/2121914/0/en/New-Publication-Shows-CareDx-s-AlloSure-May-Be-Effective-for-Monitoring-BK-Virus-in-Transplant-Patients.html
Summer.76
Summer.76, 29.10.2020 21:36 Uhr
0
Bzw in Kurzform: CareDx EPS beats by $0.16, beats on revenue https://seekingalpha.com/news/3628594-caredx-eps-beats-0_16-beats-on-revenue CareDx (NASDAQ:CDNA): Q3 Non-GAAP EPS of $0.10 beats by $0.16; GAAP EPS of -$0.06 beats by $0.14. Revenue of $53.37M (+57.9% Y/Y) beats by $1.47M.
Meistdiskutiert
Thema
1 EVOTEC Hauptdiskussion +0,43 %
2 MicroStrategy +3,90 %
3 PLUG POWER Hauptdiskussion -1,21 %
4 Lilium Aktie +13,29 %
5 für alle, die es ehrlich meinen beim Traden.
6 Schaeffler new -3,11 %
7 VW Hauptdiskussion +0,40 %
8 NEL ASA Hauptdiskussion -1,50 %
9 fox e-mobility Hauptdiskussion +100,00 %
10 TUI Hauptforum +0,17 %
Alle Diskussionen
Aktien
Thema
1 EVOTEC Hauptdiskussion +0,47 %
2 MicroStrategy +3,95 %
3 PLUG POWER Hauptdiskussion -1,19 %
4 Lilium Aktie +6,99 %
5 Schaeffler new -3,11 %
6 VW Hauptdiskussion +0,51 %
7 TUI Hauptforum -0,04 %
8 fox e-mobility Hauptdiskussion +100,00 %
9 NEL ASA Hauptdiskussion -1,36 %
10 Phunware ab 27.02.24 RS +11,57 %
Alle Diskussionen